Cargando…

Characterizing the role of the alternative NF-κB pathway in diffuse large B-cell lymphoma

Detalles Bibliográficos
Autores principales:	Ito, Daisuke, Modiano, Jaime F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624159/ http://dx.doi.org/10.1186/1753-6561-7-S2-O2

Ejemplares similares

A novel NEDD8-binding protein modulates NF-κB signaling pathway
por: Takashima, Osamu, et al.
Publicado: (2012)

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab
por: Dunleavy, K, et al.
Publicado: (2009)

NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
por: Jayawant, Eleanor, et al.
Publicado: (2023)

Impaired thymic AIRE expression underlies autoantibodies against type I IFNs in humans with inborn errors of the alternative NF-κB pathway
por: Voyer, Tom Le, et al.
Publicado: (2023)

SQSTM1/p62 regulates HTLV-1 tax mediated NF-κB activation
por: Schwob, Aurélien, et al.
Publicado: (2015)

A novel adaptive trial design: randomised evaluation of molecular guided therapy for diffuse large b-cell lymphoma with bortezomib (REMODL-B) with two interim analyses to explore safety and efficacy
por: Maishman, Tom, et al.
Publicado: (2013)

Post-translational modifications of the Tax oncoprotein of human T-cell leukemia virus control cytoplasmic and nuclear steps in Tax-mediated activation of the NF-κB pathway
por: Bex, Françoise, et al.
Publicado: (2009)

Low levels of HTLV-2 Tax conjugation to ubiquitin and SUMO do not impede Tax-mediated activation of NF-κB
por: Journo, Chloé, et al.
Publicado: (2014)

Suppression of the NF-κB cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis
por: Wakefield, A, et al.
Publicado: (2008)

HTLV-1 tax hijacks cellular ubiquitination machinery to assemble K63-linked polyubiquitin for canonical NF-κB activation
por: Ho, Yik-Khuan A, et al.
Publicado: (2015)

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma
por: Zhang, Mingzhi, et al.
Publicado: (2016)

Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas
por: Bognar, M K, et al.
Publicado: (2016)

The SUMOylation machinery is dispensable for Tax-induced NF-kB activation
por: Pène, Sabrina, et al.
Publicado: (2014)

The Truncate Mutation of Notch2 Enhances Cell Proliferation through Activating the NF-κB Signal Pathway in the Diffuse Large B-Cell Lymphomas
por: Zhang, Xinxia, et al.
Publicado: (2014)

Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway
por: Liu, Kaili, et al.
Publicado: (2020)

DSF/Cu induces antitumor effect against diffuse large B-cell lymphoma through suppressing NF-κB/BCL6 pathways
por: Zhu, Yunying, et al.
Publicado: (2022)

MiR-525-5p inhibits diffuse large B cell lymphoma progression via the Myd88/NF-κB signaling pathway
por: Guo, Xiuchen, et al.
Publicado: (2023)

Hepatitis C virus fails to activate NF-kappaB signaling in plasmacytoid dendritic cells
por: Stranska, Ruzena, et al.
Publicado: (2012)

NF-kappaB inducing kinase (NIK) is a key regulator of inflammation-induced angiogenesis
por: Noort, Ae-Ri, et al.
Publicado: (2012)

The potential role of NF-kB activation and synthesis of pro-inflammatory mediators in the pathogenesis of allergic contact dermatitis induced by thiuram
por: Kowalewski, Cezary, et al.
Publicado: (2015)

Constitutive NF-κB Activation Underlines Major Mechanism of Drug Resistance in Relapsed Refractory Diffuse Large B Cell Lymphoma
por: Turturro, Francesco
Publicado: (2015)

c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study
por: Faumont, Nathalie, et al.
Publicado: (2021)

Immunoproteasome Deficiency Modifies the Alternative Pathway of NFκB Signaling
por: Maldonado, Marcela, et al.
Publicado: (2013)

ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma
por: Sartori, Giulio, et al.
Publicado: (2021)

S231: PRIMARY MEDIASTINAL B-CELL LYMPHOMA HAVE A SUPERIOR OUTCOME COMPARED TO DIFFUSE LARGE-B-CELL LYMPHOMA TREATED WITH AXICABTAGENE CILOLEUCEL IN THE CART-SIE REAL LIFE ITALIAN STUDY
por: Chiappella, Annalisa, et al.
Publicado: (2023)

Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints
por: Gonzalez-Farre, Blanca, et al.
Publicado: (2023)

Insulin exerts anti-inflammatory effects through reduction of IKK/IκB/NF-κB pathway activation in septic rats
por: Mittestainer, F, et al.
Publicado: (2012)

S313: HEALTH ECONOMIC EVALUATION OF THIRD-LINE INTERVENTIONS FOR TRANSPLANT-INELIGIBLE RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN GERMANY
por: Sophie Kurte, Melina, et al.
Publicado: (2023)

NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells
por: Pasqualucci, Laura, et al.
Publicado: (2022)

Comparative Gene Expression Profiling Identifies Common Molecular Signatures of NF-κB Activation in Canine and Human Diffuse Large B Cell Lymphoma (DLBCL)
por: Mudaliar, Manikhandan A. V., et al.
Publicado: (2013)

Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2019)

The Alternative RelB NF-kB Subunit Exerts a Critical Survival Function upon Metabolic Stress in Diffuse Large B-Cell Lymphoma-Derived Cells
por: Nuan-Aliman, Stéphanie, et al.
Publicado: (2022)

Mutant p53 exerts its gain of function through activation of the NF-κB pathway
por: Damalas, A, et al.
Publicado: (2005)

Role of the NFκB-signaling pathway in cancer
por: Xia, Longzheng, et al.
Publicado: (2018)

Regulation of Nuclear NF-κB Oscillation by a Diffusion Coefficient and Its Biological Implications
por: Ohshima, Daisuke, et al.
Publicado: (2014)

Effect of immunodeficiency and tumor marker expression on HIV-related diffuse large B-cell lymphoma prognosis
por: Silverberg, Michael J, et al.
Publicado: (2012)

Inhibitory effects of evodiamine on zymosan-induced inflammation: inactivation of NF-κB by inhibiting IκBα phosphorylation
por: Fan, X, et al.
Publicado: (2014)

Characterization of recent thymic emigrants (RTEs), transitional B and Th17 cells in multiple sclerosis (MS)
por: Teniente-Serra, Aina, et al.
Publicado: (2011)

Comprehensive characterization of driver genes in diffuse large B cell lymphoma
por: Fan, Zheng, et al.
Publicado: (2020)

The ErbB receptor tyrosine kinases and their roles in cancer
por: Hynes, NE
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_fecmecrgl6ecefackr1ed016h2